Austin, G. I., Brown Kav, A., ElNaggar, S., Park, H., Biermann, J., Uhlemann, A.-C., Pe’er, I., & Korem, T. (2025). Processing-bias correction with DEBIAS-M improves cross-study generalization of microbiome-based prediction models. Nature Microbiology. https://doi.org/10.1038/s41564-025-01954-4

Chang, L.-C., Yin, M. T., Laird, G. M., Ritter, K. D., Shah, J. G., & Debnath, A. K. (2025). A First-in-Class Dual Degrader of Bcl-2/Bcl-xL Reverses HIV Latency and Minimizes Ex Vivo Reservoirs from Patients. International Journal of Molecular Sciences, 26(6), 2772. https://doi.org/10.3390/ijms26062772

Chellani, H. H., Human, K., Stanciu, R., Liu, A., Doucette, J., Agboglo, A., Qin, Y., Chern, T., Behnam, V., Blumenfeld, N., Victoriano, C. M., Ayers, A. G., Annavajhala, M. K., Begolo, S., Uhlemann, A., & Sia, S. K. (2025). Volumetric, Microfluidic Plasmonic RT‐PCR. Small Methods. Portico. https://doi.org/10.1002/smtd.202401988

Godinez-Macias, K. P., Chen, D., Wallis, J. L., Siegel, M. G., Adam, A., Bopp, S., Carolino, K., Coulson, L. B., Durst, G., Thathy, V., Esherick, L., Farringer, M. A., Flannery, E. L., Forte, B., Liu, T., Godoy Magalhaes, L., Gupta, A. K., Istvan, E. S., Jiang, T., … Winzeler, E. A. (2025). Revisiting the Plasmodium falciparum druggable genome using predicted structures and data mining. Npj Drug Discovery, 2(1). https://doi.org/10.1038/s44386-025-00006-5

Blair, N. J., Kopp, A., Kubin, C., Cotton, J., Yin, M. T., & Scherer, M. (2025). Association Between Inpatient Medication Treatment for Opioid Use Disorder and Reduced One-Year All-Cause Mortality in Patients With Invasive Bacterial Infections. Open Forum Infectious Diseases, 12(3). https://doi.org/10.1093/ofid/ofaf061

D’Avanzo, P. A., Bosco, J., Carnevale, C., & Zucker, J. (2024). A Qualitative Study of Doxycycline Postexposure Prophylaxis Knowledge, Attitudes, and Practices Among Health Care Providers in New York City. Sexually Transmitted Diseases, 52(4), 233–241. https://doi.org/10.1097/olq.0000000000002103

Park, J., Lindesmith, L. C., Olia, A. S., Costantini, V. P., Brewer-Jensen, P. D., Mallory, M. L., Kelley, C. E., Satterwhite, E., Longo, V., Tsybovsky, Y., Stephens, T., Marchioni, J., Martins, C. A., Huang, Y., Chaudhary, R., Zweigart, M., May, S. R., Reyes, Y., Flitter, B., … Baric, R. S. (2025). Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirus. Science Translational Medicine, 17(788). https://doi.org/10.1126/scitranslmed.ads8214

Borrell, L. N., & Castor, D. (2025). Benefits of Patient-Clinician Communication for Timely Health Care Visits in Patients Perceiving Discrimination. JAMA Network Open, 8(3), e250053. https://doi.org/10.1001/jamanetworkopen.2025.0053

Hunt, B., Pham, A., Glick, N., Sam, S., Ni, K., Meyers, K., & Nguyen, N. (2025). A Universal Approach to Educating Patients with HIV about Long-Acting Injectable Treatment for HIV. AIDS and Behavior. https://doi.org/10.1007/s10461-024-04610-w

Lee, S. W., Huz, K., Gorelick, K., Li, J., Bina, T., Matsumura, S., Yin, N., Zhang, N., Anang, Y. N. A., Sachadava, S., Servin-DeMarrais, H. I., McMahon, D. J., Lu, H. H., Yin, M. T., & Wadhwa, S. (2025). Evaluation by dental professionals of an artificial intelligence-based application to measure alveolar bone loss. BMC Oral Health, 25(1). https://doi.org/10.1186/s12903-025-05677-0

Banougnin, B. H., Castor, D., Baluku, J. B., Dzumbunu, S. P., Somefun, O. D., Sene, W., Chipanta, D., & Hertzog, L. (2025). Social Protection and HIV risk Factors among Youth in Southern Africa: An Analysis of Cross-sectional Population-based HIV Impact Assessment Surveys. AIDS and Behavior. https://doi.org/10.1007/s10461-025-04638-6

CALÌ, F., PINSINO, A., LADANYI, A., MONDELLINI, G. M., LEE, C., SAYER, G. T., KAKU, Y., URIEL, N., TAKEDA, K., AARON, J. G., YUZEFPOLSKAYA, M., & COLOMBO, P. C. (2025). Influence of Environmental Temperature on the Occurrence of Driveline Infection in Patients With LVADs. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2025.01.024

Schreidah, C. M., Jenkins, B. A., Trager, M. H., Husain, S., Coromilas, A. J., Dastidar, J. G., Miko, B. A., Zucker, J., & Gallitano, S. M. (2025). Atypical Mpox Cutaneous Presentation After Full Vaccination. The American Journal of Dermatopathology. https://doi.org/10.1097/dad.0000000000002945

Gengiah, T. N., Heck, C. J., Lewis, L., Mansoor, L. E., Harkoo, I., Myeni, N., Baum, M. M., Moss, J. A., Rooney, J. F., Hankins, C., Pozzetto, B., Abdool Karim, S. S., & Abdool Karim, Q. (2025). Acceptability of an annual tenofovir alafenamide implant for HIV prevention in South African women: findings from the CAPRISA 018 Phase I clinical trial. Journal of the International AIDS Society, 28(2). Portico. https://doi.org/10.1002/jia2.26426

Theodore, D. A., Neradilek, M., Gillespie, K., Edupuganti, S., Hinojosa, J. C., Lama, J. R., De La Grecca, R., Wu, Y. H., Davis, A., Mangini, D., Andrew, P., Marovich, M. A., Zwerski, S., Broder, G., Andrasik, M. P., Castor, D., Roxby, A. C., Cohen, M., Huang, Y., … Sobieszczyk, M. E. (2025). Brief Report: Associations Between Gender and Solicited Adverse Events After Passive Infusion of VRC01 or Placebo in HVTN 704/HPTN 085. JAIDS Journal of Acquired Immune Deficiency Syndromes, 98(4), 340–345. https://doi.org/10.1097/qai.0000000000003582

Aslam, S., Hussain, S., Haydel, B., Florman, S. S., Gilbert, A. J., Pereira, M. R., Elias, N., Hand, J., Mekeel, K., Schnickel, G., Shah, M., Ajmera, V., Tobian, A. A. R., Odim, J., Massie, A., Segev, D. L., Durand, C. M., & Rana, M. (2025). Breaking Barriers: Successful Outcomes of HCV D+/R- Transplants in HIV+ Recipients. American Journal of Transplantation. https://doi.org/10.1016/j.ajt.2025.02.007

Cascante Vega, J., Yaari, R., Robin, T., Wen, L., Zucker, J., Uhlemann, A.-C., Pei, S., & Shaman, J. (2025). Estimating nosocomial transmission of micro-organisms in hospital settings using patient records and culture data. Epidemics, 50, 100817. https://doi.org/10.1016/j.epidem.2025.100817

Joyce, M. G., Bu, W., Chen, W.-H., Gillespie, R. A., Andrews, S. F., Wheatley, A. K., Tsybovsky, Y., Jensen, J. L., Stephens, T., Prabhakaran, M., Fisher, B. E., Narpala, S. R., Bagchi, M., McDermott, A. B., Nabel, G. J., Kwong, P. D., Mascola, J. R., Cohen, J. I., & Kanekiyo, M. (2025). Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350. Immunity, 58(2), 295-308.e5. https://doi.org/10.1016/j.immuni.2025.01.010

Rawat, M., Padalino, G., Adika, E., Okombo, J., Yeo, T., Brancale, A., Fidock, D. A., Hoffmann, K. F., & Lee, M. C. S. (2025). Quinoxaline-based anti-schistosomal compounds have potent anti-plasmodial activity. PLOS Pathogens, 21(2), e1012216. https://doi.org/10.1371/journal.ppat.1012216

Titanji, B. K., & Zucker, J. (2025). Challenges in containing the global spread of mpox clade Ib. The Lancet, 405(10478), 518–519. https://doi.org/10.1016/s0140-6736(25)00139-4

Villalba, M., Fix, G. M., Schenkel, R., Chiasson, M. A., Gifford, A. L., Gordon, P., Lekas, H.-M., Yin, M. T., & Baim-Lance, A. (2025). Exploring HIV provider framings of living and aging with HIV. SSM - Qualitative Research in Health, 7, 100526. https://doi.org/10.1016/j.ssmqr.2025.100526

Morano, N. C., Guo, Y., Becker, J. E., Li, Z., Yu, J., Ho, D. D., Shapiro, L., & Kwong, P. D. (2025). Structure of a zoonotic H5N1 hemagglutinin reveals a receptor-binding site occupied by an auto-glycan. Structure. https://doi.org/10.1016/j.str.2025.01.001

Mezochow, A. K., Pereira, M. R., Ortega-Legaspi, J., & Lautenbach, E. (2025). P-2252. Bloodstream Infections in Heart Transplant Recipients Following the 2018 OPTN Heart Allocation Policy Change. Open Forum Infectious Diseases, 12(Supplement_1). https://doi.org/10.1093/ofid/ofae631.2405

Blair, N., Kopp, A., Kubin, C. J., Cotton, J., Yin, M., & Scherer, M. (2025). P-862. Hospital administered MOUD is associated with decreased one-year mortality among PWUD admitted with bloodstream infections. Open Forum Infectious Diseases, 12(Supplement_1). https://doi.org/10.1093/ofid/ofae631.1054

Hokunson, T. W., Hernandez, E., Annavajhala, M. K., Uhlemann, A.-C., & Gomez-Simmonds, A. (2025). P-1340. Genetic Factors Associated with Cefepime and Piperacillin/Tazobactam Resistance in Clinical Extended-Spectrum Beta-Lactamase-Producing Enterobacterales from the Intensive Care Unit. Open Forum Infectious Diseases, 12(Supplement_1). https://doi.org/10.1093/ofid/ofae631.1517

Metlay, J., Blair, N., Scherer, M., Kodali, K., Sethi, S., Parikh, S. A., Zilinyi, R., & Sobieszczyk, M. E. (2025). P-938. Percutaneous Mechanical Aspiration in Drug Use Associated-Infective Endocarditis. Open Forum Infectious Diseases, 12(Supplement_1). https://doi.org/10.1093/ofid/ofae631.1129

Leocadio, C., Garcia, E. A., Lash, M., Berardi, J., Chan, J., Chasan, R., Esquivel, B. C., Foote, M. K., Glesby, M. J., Guerra, A., Harris, A. B., Knutsen, D., Mannheimer, S., Mazo, D., McLean, J., McPherson, T. D., Meyerowitz, E., Mgbako, O., Patel, G., … Wong, M. (2025). 214. Clinical Characteristics and Outcomes of Patients Treated with Tecovirimat for Mpox Disease: A Large Cohort in New York City. Open Forum Infectious Diseases, 12(Supplement_1). https://doi.org/10.1093/ofid/ofae631.072

Garzia, C., Nelson, B., Loo, A., Demenagas, N., & Kubin, C. J. (2025). P-2309. Assessment of Risk Factors Associated with Subtherapeutic Posaconazole Levels. Open Forum Infectious Diseases, 12(Supplement_1). https://doi.org/10.1093/ofid/ofae631.2461

Rashidi, K., Kubin, C. J., Wu, G., Nelson, B., & Uhlemann, A.-C. (2025). P-1476. Cefiderocol Treatment Outcomes and Risk Factors for Gram-negative Bacterial Infection Treatment Failure. Open Forum Infectious Diseases, 12(Supplement_1). https://doi.org/10.1093/ofid/ofae631.1646

Parkinson, M., Saylor, M., Villarreal, J., Chaudhuri, S., Gunaratne, S., & Olender, S. (2025). P-1441. Demographic and Clinical Characteristics of New Migrant Patients with HIV in a New York City Open Access HIV Primary Care Clinic. Open Forum Infectious Diseases, 12(Supplement_1). https://doi.org/10.1093/ofid/ofae631.1614

Heck, C. J., Theodore, D. A., Autry, A., Sovic, B., Yang, C., Anderson-Burnett, S. A., Ray, C., Austin, E., Rotbert, J., Zucker, J., Catallozzi, M., Sobieszczyk, M. E., & Castor, D. (2025). Predictors, patterns, and correlates of moderate-severe psychological distress among New York City College Students during Waves 2–4 of COVID-19. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-025-86364-6

Glance, L. G., Joynt Maddox, K. E., Stone, P. W., Shang, J., Furuya, E. Y., Chastain, A. M., Lee, J. W., Morse-Karzen, B., & Dick, A. W. (2025). COVID-19 Pandemic and Racial and Ethnic Disparities in Long-Term Nursing Home Stay or Death Following Hospital Discharge. JAMA Network Open, 8(1), e2456816. https://doi.org/10.1001/jamanetworkopen.2024.56816

Macesic, N., Uhlemann, A.-C., & Peleg, A. Y. (2025). Multidrug-resistant Gram-negative bacterial infections. The Lancet, 405(10474), 257–272. https://doi.org/10.1016/s0140-6736(24)02081-6

Mason, R. D., Zhang, B., Morano, N. C., Shen, C.-H., McKee, K., Heimann, A., Du, R., Nazzari, A. F., Hodges, S., Kanai, T., Lin, B. C., Louder, M. K., Doria-Rose, N. A., Zhou, T., Shapiro, L., Roederer, M., Kwong, P. D., & Gorman, J. (2025). Structural development of the HIV-1 apex-directed PGT145-PGDM1400 antibody lineage. Cell Reports, 44(1), 115223. https://doi.org/10.1016/j.celrep.2024.115223

Park, H., Lynch, E., Tillman, A., Lewis, K., Jin, Z., Uhlemann, A.-C., Abrams, J. A., & Freedberg, D. E. (2025). A phase 2 randomized, placebo-controlled trial of inulin for the prevention of gut pathogen colonization and infection among patients admitted to the intensive care unit for sepsis. Critical Care, 29(1). https://doi.org/10.1186/s13054-024-05232-3

May, M. S., Park, H., Moallem, D. H., Seeram, D., Dajiang, S., Hibshoosh, H., Jamison, J. K., Uhlemann, A.-C., & Manji, G. A. (2024). Low Bacterial Biomass in Human Pancreatic Cancer and Adjacent Normal Tissue. International Journal of Molecular Sciences, 26(1), 140. https://doi.org/10.3390/ijms26010140

Dos Santos, F. C., Batey, D. S., Kay, E. S., Jia, H., Wood, O. R., Abua, J. A., Olender, S. A., & Schnall, R. (2025). The effect of a combined mHealth and community health worker intervention on HIV self-management. Journal of the American Medical Informatics Association. https://doi.org/10.1093/jamia/ocae322

Gorman, J., Du, R., Lai, Y.-T., Ahmadi, M. S., King, H. A. D., Song, K., Manalang, K., Gonelli, C. A., Schramm, C. A., Cheng, C., Nguyen, R., Ambrozak, D., Druz, A., Shen, C.-H., Yang, Y., Douek, D. C., Kwong, P. D., Roederer, M., & Mason, R. D. (2025). Isolation and structure of broad SIV-neutralizing antibodies reveal a proximal helical MPER epitope recognized by a rhesus multi-donor class. Cell Reports, 44(1), 115163. https://doi.org/10.1016/j.celrep.2024.115163

Hong, S. J., Resnick, S. J., Iketani, S., Cha, J. W., Albert, B. A., Fazekas, C. T., Chang, C.-W., Liu, H., Dagan, S., Abagyan, M. R., Fajtová, P., Culbertson, B., Brace, B., Reddem, E. R., Forouhar, F., Glickman, J. F., Balkovec, J. M., Stockwell, B. R., Shapiro, L., … Chavez, A. (2025). A multiplex method for rapidly identifying viral protease inhibitors. Molecular Systems Biology, 21(2), 158–172. https://doi.org/10.1038/s44320-024-00082-1

Snow, M. A., Annavajhala, M. K., Moscovitz, S. Z., Uhlemann, A.-C., & Debelenko, L. (2025). Placental Infection with Different SARS-CoV-2 Variants Leading to Stillbirth: Report of Two Cases. COVID, 5(1), 8. https://doi.org/10.3390/covid5010008

Liu, H., Zask, A., Forouhar, F., Iketani, S., Williams, A., Vaz, D. R., Habashi, D., Choi, K., Resnick, S. J., Hong, S. J., Lovett, D. H., Bai, T., Chavez, A., Ho, D. D., & Stockwell, B. R. (2025). Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening. Nature Communications, 16(1). https://doi.org/10.1038/s41467-024-55421-5

Perelman, S. C., Ansari, T., Yin, M. T., Gordon, P. G., Nguyen, N., Evangelidis-Sakellson, V., Kunzel, C., Meyers, K., Castor, D., Blanchard, A., & Albert, D. A. (2025). Leveraging Clinical Decision Support in Dental Settings to Bridge HIV Testing Gaps and Contribute to Ending the Epidemic. ACI Open, 09(01), e1–e8. CLOCKSS. https://doi.org/10.1055/a-2500-7594

Knaab, T. C., Moritz, A., Pessanha de Carvalho, L., Klein, S., Lungerich, B., Lohse, K., Kruse, L., Mombo-Ngoma, G., Orta, L., Thibaud, J. L., de Villiers, K. A., Fidock, D. A., Burckhardt, B. B., Held, J., Wittlin, S., & Kurz, T. (2024). TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01465

Guo, Y., Waltari, E., Lu, H., Sheng, Z., & Wu, X. (2024). Novel rhesus macaque immunoglobulin germline genes identified by three sequencing approaches. Frontiers in Immunology, 15. https://doi.org/10.3389/fimmu.2024.1506348

Cale, E. M., Shen, C.-H., Olia, A. S., Radakovich, N. A., Rawi, R., Yang, Y., Ambrozak, D. R., Bennici, A. K., Chuang, G.-Y., Crooks, E. D., Driscoll, J. I., Lin, B. C., Louder, M. K., Madden, P. J., Messina, M. A., Osawa, K., Stewart-Jones, G. B. E., Verardi, R., Vrakas, Z., … Gorman, J. (2024). A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies. Cell Reports, 43(12), 115010. https://doi.org/10.1016/j.celrep.2024.115010

Martinez-Vega, R., Ishengoma, D. S., Gosling, R., Rosenthal, P. J., Dondorp, A., Barnes, K. I., Nsanzabana, C., Djimde, A. A., Ochola-Oyier, L. I., Tibenderana, J., Chimumbwa, J., Golassa, L., Kapologwe, N. A., Mbacham, W. F., Kamya, M. R., Fidock, D. A., Komatsu, R., von Seidlein, L., & Dhorda, M. (2025). Regional action needed to halt antimalarial drug resistance in Africa. The Lancet, 405(10472), 7–10. https://doi.org/10.1016/s0140-6736(24)02706-5

Li, M., Hunt, B., Balani, B., Ogedegbe, C., Gordon, P., Hayden, J., Glick, N., Chang, A., Wang, S., Caponi, M., Yarber‐Cambron, L., Bhat, S., Ward, T., & Suryadevara, M. (2024). A US‐Based Multi‐Site Pilot to Screen Hepatitis B Surface Antigen‐Positive Patients for Hepatitis D. Journal of Viral Hepatitis, 32(1). Portico. https://doi.org/10.1111/jvh.14043

Edupuganti, S., Hurt, C. B., Stephenson, K. E., Huang, Y., Paez, C. A., Yu, C., Yen, C., Hanscom, B., He, Z., Miner, M. D., Gamble, T., Heptinstall, J., Seaton, K. E., Domin, E., Lin, B. C., McKee, K., Doria-Rose, N., Regenold, S., Spiegel, H., … Afemata, S. (2024). Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial. The Lancet HIV. https://doi.org/10.1016/s2352-3018(24)00247-9

Hagenah, L. M., Yeo, T., Schindler, K. A., Jeon, J. H., Bloxham, T. S., Small-Saunders, J. L., Mok, S., & Fidock, D. A. (2024). Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance Are Infrequent and Impart a Major Fitness Cost. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae617